|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 259.06 USD | -0.77% |
|
+7.37% | +14.26% |
| 07-02 | AbbVie, Other Healthcare Stocks Rise as Trump Administration Reportedly Targets Hospital Drug Markups | MT |
| 07-01 | US Committee Launches Probe Against Five Drugmakers Over China Clinical Trials | MT |
| Market Cap | 461B 403B 370B 345B 654B 43,912B 665B 4,456B 1,727B 21,538B 1,732B 1,694B 74,215B | P/E 2026 * |
32.2x | P/E 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 517B 452B 415B 387B 733B 49,225B 746B 4,995B 1,936B 24,144B 1,941B 1,899B 83,194B | EV / Sales 2026 * |
7.69x | EV / Sales 2027 * | 6.98x |
| Free-Float |
95.71% | Yield 2026 * |
2.65% | Yield 2027 * | 2.77% |
Last Transcript: AbbVie Inc.
| 1 day | +3.99% | ||
| 1 week | +7.37% | ||
| Current month | +3.75% | ||
| 1 month | +21.20% | ||
| 3 months | +25.01% | ||
| 6 months | +13.85% | ||
| Current year | +14.26% |
| 1 week | 247.56 |  | 261.64 |
| 1 month | 215.37 | | 261.64 |
| Current year | 190.75 | | 261.64 |
| 1 year | 184.63 | | 261.64 |
| 3 years | 132.7 | | 261.64 |
| 5 years | 105.56 | | 261.64 |
| 10 years | 55.06 | | 261.64 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 2022-06-22 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 2012-12-31 |
William Burnside
BRD | Director/Board Member | 74 | 2012-12-31 |
Edward Rapp
BRD | Director/Board Member | 68 | 2012-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-07 | Free | Director | 1,118 | 0.0001% | ||
| 05-07 | Free | Director | 1,118 | 0.0001% | ||
| 05-07 | Free | Director | 1,118 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.77% | +7.37% | +36.87% | +93.77% | 461B | |
| +3.45% | +7.65% | +55.77% | +158.84% | 1,082B | |
| -1.16% | +7.42% | +69.09% | +58.92% | 633B | |
| +3.36% | -1.94% | +26.41% | +20.22% | 339B | |
| -0.54% | +1.17% | +41.96% | +39.64% | 301B | |
| -0.23% | +1.49% | +32.40% | +44.75% | 292B | |
| -1.97% | +2.58% | -25.52% | -39.75% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +0.40% | +6.00% | +17.72% | +70.33% | 163B | |
| +1.83% | +2.75% | -3.95% | -33.70% | 139B | |
| Average | +1.52% | +2.22% | +27.68% | +48.15% | 383.83B | |
| Weighted average by Cap. | +1.39% | +1.91% | +40.14% | +77.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.24B 58.75B 53.95B 50.31B 95.38B 6,401B 96.99B 650B 252B 3,140B 252B 247B 10,818B | 72.73B 63.55B 58.36B 54.42B 103B 6,924B 105B 703B 272B 3,396B 273B 267B 11,702B |
| Net income | 14.56B 12.72B 11.68B 10.9B 20.66B 1,386B 21B 141B 54.52B 680B 54.67B 53.49B 2,343B | 19.02B 16.62B 15.26B 14.23B 26.99B 1,811B 27.44B 184B 71.23B 888B 71.43B 69.88B 3,061B |
| Net Debt | 55.81B 48.77B 44.78B 41.76B 79.17B 5,313B 80.51B 539B 209B 2,606B 210B 205B 8,980B | 46.34B 40.49B 37.18B 34.67B 65.73B 4,411B 66.84B 448B 173B 2,164B 174B 170B 7,455B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | US$261.07 | +3.99% | 7,114,422 |
| 26-07-01 | US$251.06 | -0.23% | 6,987,982 |
| 26-06-30 | US$251.64 | -1.05% | 6,999,707 |
| 26-06-29 | US$254.31 | +0.38% | 9,760,531 |
| 26-06-26 | US$253.35 | +4.20% | 52,635,078 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
Select your edition
All financial news and data tailored to specific country editions
